Truitt Joseph
SEC Form 4 insider trading activity
Truitt Joseph has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Nov 12, 2026.
On the most recent filing, Truitt Joseph is listed as Director at Larimar Therapeutics, Inc. Inside the rolling window, Truitt Joseph reported 1 open-market purchase totaling $10K in LRMR and no open-market sales.
Companies traded
Other insiders at LRMR
Insider Buying
$10K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Truitt Joseph made?
Truitt Joseph has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Truitt Joseph trade?
Truitt Joseph has filed SEC Form 4 disclosures for 1 company, including LRMR.
When was Truitt Joseph's most recent SEC Form 4 filing?
Truitt Joseph's most recent SEC Form 4 filing on Tracefour is dated Nov 12, 2026.
What is Truitt Joseph's total buy and sell value in the current window?
Inside the rolling retention window, Truitt Joseph bought $10K and sold $0 based on SEC Form 4 filings.
What was Truitt Joseph's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 3,500 LRMR shares on 2026-11-11, worth $10K, per SEC Form 4 filings.